Skip to main content
Top
Published in: Translational Stroke Research 3/2014

01-06-2014 | Editorial

Intracerebral Hemorrhage: A Multimodality Approach to Improving Outcome

Authors: Aditya S. Pandey, Guohua Xi

Published in: Translational Stroke Research | Issue 3/2014

Login to get access

Excerpt

Intracerebral hemorrhage (ICH) is caused by a heterogeneous group of pathologies, but its injury upon cerebral tissue arises from similar mechanisms: direct cerebral tissue destruction, hematoma expansion, mass effect, inflammation, and toxicity associated with blood components and hemoglobin metabolic products such as iron [18]. Primary ICH affects nearly four million individuals worldwide with 40 % of the patient unable to survive longer than 1 month [9]. Primary ICH is thought to arise from structural damage to perforating vessels leading to aneurysmal formation and subsequent rupture. Hypertension leads to degenerative changes within the vascular wall leading to vessel wall weakness and aneurysm formation while amyloid deposition within the vessel wall can lead to fibrinoid necrosis and thus subsequent vessel rupture. Most certainly, ideal treatment of any pathology lies in prevention, and thus managing hypertension is ideal in preventing ICH as well as recurrent episodes. …
Literature
1.
go back to reference Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720–31.PubMedCrossRef Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720–31.PubMedCrossRef
2.
go back to reference Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 2006;5:53–63.PubMedCrossRef Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 2006;5:53–63.PubMedCrossRef
3.
go back to reference Bodmer D, Vaughan KA, Zacharia BE, Hickman ZL, Connolly ES. The molecular mechanisms that promote edema after intracerebral hemorrhage. Transl Stroke Res. 2012;3:S52–61.CrossRef Bodmer D, Vaughan KA, Zacharia BE, Hickman ZL, Connolly ES. The molecular mechanisms that promote edema after intracerebral hemorrhage. Transl Stroke Res. 2012;3:S52–61.CrossRef
4.
go back to reference Rincon F, Mayer SA. Intracerebral hemorrhage: clinical overview and pathophysiologic concepts. Transl Stroke Res. 2012;3:10–24.PubMedCrossRef Rincon F, Mayer SA. Intracerebral hemorrhage: clinical overview and pathophysiologic concepts. Transl Stroke Res. 2012;3:10–24.PubMedCrossRef
6.
go back to reference Liu DZ, Sharp FR. Excitatory and mitogenic signaling in cell death, blood–brain barrier breakdown, and BBB repair after intracerebral hemorrhage. Transl Stroke Res. 2012;3:S62–9.CrossRef Liu DZ, Sharp FR. Excitatory and mitogenic signaling in cell death, blood–brain barrier breakdown, and BBB repair after intracerebral hemorrhage. Transl Stroke Res. 2012;3:S62–9.CrossRef
7.
go back to reference Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894–908.PubMedCrossRef Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894–908.PubMedCrossRef
8.
go back to reference Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab. 2003;23:629–52.PubMedCrossRef Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab. 2003;23:629–52.PubMedCrossRef
9.
go back to reference Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408.PubMedCentralPubMedCrossRef Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408.PubMedCentralPubMedCrossRef
10.
go back to reference Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370–5.PubMedCrossRef Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370–5.PubMedCrossRef
11.
go back to reference Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.PubMedCrossRef Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.PubMedCrossRef
12.
go back to reference Mayer SA. Recombinant activated factor VII for acute intracerebral hemorrhage. Stroke. 2007;38:763–7.PubMedCrossRef Mayer SA. Recombinant activated factor VII for acute intracerebral hemorrhage. Stroke. 2007;38:763–7.PubMedCrossRef
13.
go back to reference Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.PubMedCrossRef Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.PubMedCrossRef
14.
go back to reference Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedCrossRef Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedCrossRef
15.
go back to reference Mould WA, Carhuapoma JR, Muschelli J, et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013;44:627–34.PubMedCrossRef Mould WA, Carhuapoma JR, Muschelli J, et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013;44:627–34.PubMedCrossRef
16.
go back to reference Selim M, Yeatts S, Goldstein JN, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42:3067–74.PubMedCentralPubMedCrossRef Selim M, Yeatts S, Goldstein JN, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42:3067–74.PubMedCentralPubMedCrossRef
17.
go back to reference Morgenstern LB. Treatment of intracerebral hemorrhage-is the glass half full or half empty? Transl Stroke Res. 2012;3:4–5.PubMedCrossRef Morgenstern LB. Treatment of intracerebral hemorrhage-is the glass half full or half empty? Transl Stroke Res. 2012;3:4–5.PubMedCrossRef
18.
go back to reference Xi G, Keep RF. Intracerebral hemorrhage: mechanisms and therapies. Transl Stroke Res. 2012;3:1–3.PubMedCrossRef Xi G, Keep RF. Intracerebral hemorrhage: mechanisms and therapies. Transl Stroke Res. 2012;3:1–3.PubMedCrossRef
19.
go back to reference Xi G, Strahle J, Hua Y, Keep RF. Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog Neurobiol. 2014;115C:45–63.CrossRef Xi G, Strahle J, Hua Y, Keep RF. Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog Neurobiol. 2014;115C:45–63.CrossRef
Metadata
Title
Intracerebral Hemorrhage: A Multimodality Approach to Improving Outcome
Authors
Aditya S. Pandey
Guohua Xi
Publication date
01-06-2014
Publisher
Springer US
Published in
Translational Stroke Research / Issue 3/2014
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-014-0344-z

Other articles of this Issue 3/2014

Translational Stroke Research 3/2014 Go to the issue